Paris-Dakner Nanolifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 0.17 M
About Paris-Dakner Nanolifesciences
Paris-Dakner Nanolifesciences Private Limited (PNPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2009 and has a history of 15 years and five months. Its registered office is in Madurai, Tamil Nadu, India.
The Corporate was formerly known as Glorex Medicare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.17 M.
Sathish Muthupillai, Vignesh Mohanasundaram, Kunasekaran Pradeep, and Three other members serve as directors at the Company.
Company Details
-
Location
Madurai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15323TN2009PTC072701
-
Company No.
072701
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Aug 2009
-
Date of AGM
30 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Paris-Dakner Nanolifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sathish Muthupillai
|
Managing Director | 01-Feb-2014 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vignesh Mohanasundaram
|
Additional Director | 29-Mar-2014 | Current |
|
Kunasekaran Pradeep
|
Additional Director | 29-Mar-2014 | Current |
|
Anandvivek Bajpai
|
Director | 14-Jun-2013 | Current |
|
Mohanasundaram Umarani
|
Director | 14-Jun-2013 | Current |
|
Mohanasundram Madhumathi
|
Additional Director | 25-Mar-2014 | Current |
Financial Performance of Paris-Dakner Nanolifesciences.
Enhance accessibility to Paris-Dakner Nanolifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paris-Dakner Nanolifesciences?
Unlock access to Paris-Dakner Nanolifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Kalysta Pharmaceuticals Private LimitedAnandvivek Bajpai is a mutual person
-
Paris-Dakner Microspherules Private Limited
Mohanasundaram Umarani and Mohanasundram Madhumathi are mutual person
Charges (Loans)
₹0.17 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2010 | Indian Overseas Bank | ₹0.17 M | Open |
How Many Employees Work at Paris-Dakner Nanolifesciences?
Unlock and access historical data on people associated with Paris-Dakner Nanolifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paris-Dakner Nanolifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paris-Dakner Nanolifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
